Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Organogenesis Hldgs
(NASDAQ:ORGO)
Intraday
$3.03
0.75
[32.89%]
After-Hours
$3.03
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$3.03
0.75
[32.89%]
At close: May 10
$3.03
0
[0.00%]
After Hours: 7:55PM EDT
Get Report
Watch
Q1 2024 Earnings were released on Thu May 9th, after the market close
The most recent conference call was at 17:00 PM, 3 days ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Organogenesis Hldgs Stock (NASDAQ:ORGO)
Organogenesis Hldgs Stock (NASDAQ: ORGO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, May 10, 2024
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
2 days ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
2 days ago
Organogenesis shares are trading higher following better-than-expected Q1 earnings.
Benzinga Newsdesk
-
2 days ago
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
2 days ago
Thursday, May 09, 2024
Organogenesis Reaffirms 2024 Guidance; Sees Net Revenue $445M-$470M vs $454.69M Est.
Benzinga Newsdesk
-
2 days ago
Organogenesis Hldgs Q1 2024 Adj EPS $(0.01) Beats $(0.03) Estimate, Sales $109.976M Beat $101.050M Estimate
Benzinga Newsdesk
-
2 days ago
Thursday, May 02, 2024
Organogenesis shares are trading higher after the company announced that its Phase 3 randomized control trial evaluating the safety and efficacy of ReNu achieved its primary endpoint.
Benzinga Newsdesk
-
May 2, 2024, 7:45AM
Organogenesis Achieves Primary Endpoint In Phase 3 Clinical Trial Of ReNu for Knee Osteoarthritis
Benzinga Newsdesk
-
May 2, 2024, 7:44AM
Thursday, April 25, 2024
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Apr 25, 2024, 1:57PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Apr 25, 2024, 12:31PM
Wednesday, April 03, 2024
Organogenesis Announced Favorable Ruling From United States District Court Dismissing Securities Fraud Case
Benzinga Newsdesk
-
Apr 3, 2024, 7:33AM
Friday, March 01, 2024
Cantor Fitzgerald Reiterates Overweight on Organogenesis Hldgs, Maintains $5 Price Target
Benzinga Newsdesk
-
Mar 1, 2024, 9:35AM
Thursday, February 29, 2024
Organogenesis Holdings Sees FY24 Revenue $445M-$470M Vs $455.949M Est.
Benzinga Newsdesk
-
Feb 29, 2024, 4:38PM
Recap: Organogenesis Hldgs Q4 Earnings
Benzinga Insights
-
Feb 29, 2024, 4:15PM
Organogenesis Hldgs Q4 2023 GAAP EPS $0.010, Inline, Sales $99.651M Miss $109.050M Estimate
Benzinga Newsdesk
-
Feb 29, 2024, 4:13PM
Earnings Scheduled For February 29, 2024
Benzinga Insights
-
Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
A Preview Of Organogenesis Hldgs's Earnings
Benzinga Insights
-
Feb 28, 2024, 2:01PM
Wednesday, February 07, 2024
Cantor Fitzgerald Initiates Coverage On Organogenesis Hldgs with Overweight Rating, Announces Price Target of $5
Benzinga Newsdesk
-
Feb 7, 2024, 7:29AM
Wednesday, December 27, 2023
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Dec 27, 2023, 2:11PM
Organogenesis Holdings shares are trading higher after BTIG maintained a Buy rating on the stock and raised its price target from $4 to $6.
Benzinga Newsdesk
-
Dec 27, 2023, 11:18AM
Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
-
Dec 27, 2023, 9:06AM
BTIG Maintains Buy on Organogenesis Hldgs, Raises Price Target to $6
Benzinga Newsdesk
-
Dec 27, 2023, 7:27AM
Tuesday, November 14, 2023
Morgan Stanley Maintains Equal-Weight on Organogenesis Hldgs, Raises Price Target to $3.5
Benzinga Newsdesk
-
Nov 14, 2023, 9:31AM
Friday, November 10, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Nov 10, 2023, 12:31PM
Organogenesis Holdings shares are trading higher after the company reported Q3 financial results and issued FY23 revenue guidance.
Benzinga Newsdesk
-
Nov 10, 2023, 12:10PM
Thursday, November 09, 2023
Organogenesis Sees FY23 Net Revenue $433M-$443M
Benzinga Newsdesk
-
Nov 9, 2023, 4:48PM
Organogenesis Q3 EPS $0.02, Net Revenue $108.5M vs $111.4M Est.
Benzinga Newsdesk
-
Nov 9, 2023, 4:48PM
Earnings Scheduled For November 9, 2023
Benzinga Insights
-
Nov 9, 2023, 6:52AM
Thursday, September 28, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Sep 28, 2023, 1:31PM
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Sep 28, 2023, 1:04PM
Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday
Lisa Levin
-
Sep 28, 2023, 10:39AM
Friday, August 11, 2023
The Latest Analyst Ratings for Organogenesis Hldgs
Benzinga Insights
-
Aug 11, 2023, 2:00PM
Morgan Stanley Maintains Equal-Weight on Organogenesis Hldgs, Lowers Price Target to $3
Benzinga Newsdesk
-
Aug 11, 2023, 9:04AM
Thursday, August 10, 2023
BTIG Maintains Buy on Organogenesis Hldgs, Lowers Price Target to $4
Benzinga Newsdesk
-
Aug 10, 2023, 3:47PM
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Aug 10, 2023, 1:17PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Aug 10, 2023, 9:06AM
Organogenesis shares are trading lower after the company reported Q2 financial results and withdrew its FY23 guidance.
Benzinga Newsdesk
-
Aug 10, 2023, 8:17AM
Wednesday, August 09, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Aug 9, 2023, 5:32PM
Organogenesis Withdraws Previously Announced FY23 Guidance, Originally Issued On May 10, 2023
Benzinga Newsdesk
-
Aug 9, 2023, 4:58PM
Organogenesis shares are trading lower after the company reported Q2 financial results and withdrew its FY23 guidance.
Benzinga Newsdesk
-
Aug 9, 2023, 4:22PM
Organogenesis Q2 Adj EPS $0.46 Beats $0.02 Estimate, Sales $117.32M Beat $115.10M Estimate
Benzinga Newsdesk
-
Aug 9, 2023, 4:16PM
Earnings Scheduled For August 9, 2023
Benzinga Insights
-
Aug 9, 2023, 4:54AM
Friday, July 14, 2023
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
Lisa Levin
-
Jul 14, 2023, 10:48AM
Thursday, June 15, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
Benzinga Insights
-
Jun 15, 2023, 11:01AM
Morgan Stanley Initiates Coverage On Organogenesis Hldgs with Equal-Weight Rating, Announces Price Target of $5
Benzinga Newsdesk
-
Jun 15, 2023, 6:25AM
Wednesday, May 24, 2023
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
May 24, 2023, 12:48PM
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
Benzinga Insights
-
May 24, 2023, 11:00AM
Abercrombie & Fitch, Urban Outfitters, Photronics And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
-
May 24, 2023, 10:41AM
Organogenesis shares are trading higher after BTIG upgraded the stock from Neutral to Buy and announced a $10 price target.
Benzinga Newsdesk
-
May 24, 2023, 8:29AM
BTIG Upgrades Organogenesis Hldgs to Buy, Announces $10 Price Target
Benzinga Newsdesk
-
May 24, 2023, 4:24AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch